英国ICU疑似呼吸机相关肺炎患者中的肺曲霉病
基于英国两项前瞻性研究,对194例非中性粒细胞减少的疑似呼吸机相关肺炎成人患者进行真菌学检测,按临床、影像和真菌学标准定义可能肺曲霉病。估计患病率为12.4%(95%CI 8.1-17.8),该组患者重症监护住院时间显著延长(25.5 vs 15.5天,P=0.02),ICU死亡率数值更高但无统计学差异(33.3% vs 22.8%,P=0.23)。
要点
- 疑似VAP患者中可能肺曲霉病患病率为12.4%(95%CI 8.1-17.8)。
- 可能肺曲霉感染组重症监护住院时间显著延长(25.5 vs 15.5天,P=0.02)。
- ICU死亡率两组无统计学差异(33.3% vs 22.8%,P=0.23)。
核心结论
- 在英国多中心疑似VAP成人队列中,可能肺曲霉病估计患病率为12.4%,提示临床应考虑该病。
研究设计与样本
- 两项英国前瞻性研究纳入360例疑似VAP成人,其中194例非中性粒细胞减少患者有储存血清和BALF用于真菌学检测。
主要发现
- 194例中24例符合可能肺曲霉感染定义,估计患病率12.4%(95%CI 8.1-17.8)。
- 24例均有GM阳性:血清4例、BALF 16例、两者均阳性4例;3例BALF培养出曲霉。
- 可能肺曲霉感染组中位重症监护住院时间显著更长(25.5 vs 15.5天,P=0.02)。
- ICU死亡率数值更高但无统计学差异(33.3% vs 22.8%,P=0.23)。
关键数值与推荐
- 可能肺曲霉感染定义包含临床、影像和真菌学标准。
- 真菌学标准包括组织学或显微镜阳性、BALF培养阳性、BALF GM光学指数≥1或血清GM≥0.5。
临床怎么用
- 对疑似VAP患者,尤其非传统高危人群,应考虑肺曲霉病可能并进行真菌学检测。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale:Aspergillus infection in patients with suspected ventilator-associated pneumonia remains uncharacterized because of the absence of a disease definition and limited access to sensitive diagnostic tests.Objectives: To estimate the prevalence and outcomes of Aspergillus infection in adults with suspected ventilator-associated pneumonia.Methods: Two prospective UK studies recruited 360 critically ill adults with new or worsening alveolar shadowing on chest X-ray and clinical/hematological parameters supporting suspected ventilator-associated pneumonia. Stored serum and BAL fluid were available from 194 nonneutropenic patients and underwent mycological testing. Patients were categorized as having probable Aspergillus infection using a definition comprising clinical, radiological, and mycological criteria. Mycological criteria included positive histology or microscopy, positive BAL fluid culture, galactomannan optical index of 1 or more in BAL fluid or 0.5 or more in serum.Measurements and Main Results: Of 194 patients evaluated, 24 met the definition of probable Aspergillus infection, giving an estimated prevalence of 12.4% (95% confidence interval, 8.1-17.8). All 24 patients had positive galactomannan in serum (n = 4), BAL fluid (n = 16), or both (n = 4); three patients cultured Aspergillus sp. in BAL fluid. Patients with probable Aspergillus infection had a significantly longer median duration of critical care stay (25.5 vs. 15.5 d, P = 0.02). ICU mortality was numerically higher in this group, although this was not statistically significant (33.3% vs. 22.8%; P = 0.23).Conclusions: The estimated prevalence for probable Aspergillus infection in this geographically dispersed multicenter UK cohort indicates that this condition should be considered when investigating patients with suspected ventilator-associated pneumonia, including patient groups not previously recognized to be at high risk of aspergillosis.
引用
- Loughlin L, Hellyer TP, White PL, et al. Pulmonary Aspergillosis in Patients with Suspected Ventilator-associated Pneumonia in UK ICUs. Am J Respir Crit Care Med. 2020. PMID: 32609533. doi:10.1164/rccm.202002-0355OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。